DE60236806D1 - Transkutane immunisierung gegen papillomavirus mit virusähnlichen papillomaviruspartikeln - Google Patents

Transkutane immunisierung gegen papillomavirus mit virusähnlichen papillomaviruspartikeln

Info

Publication number
DE60236806D1
DE60236806D1 DE60236806T DE60236806T DE60236806D1 DE 60236806 D1 DE60236806 D1 DE 60236806D1 DE 60236806 T DE60236806 T DE 60236806T DE 60236806 T DE60236806 T DE 60236806T DE 60236806 D1 DE60236806 D1 DE 60236806D1
Authority
DE
Germany
Prior art keywords
papilloma
virusual
virus particles
immunization against
transcutaneous immunization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60236806T
Other languages
English (en)
Inventor
Robert C Rose
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Rochester
Original Assignee
University of Rochester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Rochester filed Critical University of Rochester
Application granted granted Critical
Publication of DE60236806D1 publication Critical patent/DE60236806D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20023—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
DE60236806T 2001-08-13 2002-08-09 Transkutane immunisierung gegen papillomavirus mit virusähnlichen papillomaviruspartikeln Expired - Lifetime DE60236806D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31190101P 2001-08-13 2001-08-13
US37702302P 2002-05-01 2002-05-01
PCT/US2002/025391 WO2003103570A2 (en) 2001-08-01 2002-08-09 Transcutaneous immunization against papillomavirus with papillomavirus virus-like particles

Publications (1)

Publication Number Publication Date
DE60236806D1 true DE60236806D1 (de) 2010-08-05

Family

ID=29739302

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60236806T Expired - Lifetime DE60236806D1 (de) 2001-08-13 2002-08-09 Transkutane immunisierung gegen papillomavirus mit virusähnlichen papillomaviruspartikeln

Country Status (7)

Country Link
US (1) US7247433B2 (de)
EP (1) EP1425423B1 (de)
AT (1) ATE471990T1 (de)
AU (1) AU2002367977B2 (de)
CA (1) CA2457804C (de)
DE (1) DE60236806D1 (de)
WO (1) WO2003103570A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60234375D1 (de) 2001-09-14 2009-12-24 Cytos Biotechnology Ag VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG
US20040137004A1 (en) * 2002-03-19 2004-07-15 Glenn Gregory M Patch for transcutaneous immunization
FR2887457B1 (fr) * 2005-06-23 2007-10-05 Fond Bettencourt Schueller Vaccination par ciblage transcutane
US8778351B2 (en) 2006-08-30 2014-07-15 University Of Rochester Combined human papillomavirus VLP/gene delivery system and use thereof as a vaccine for prophylaxis and immunotherapy of infectious diseases and tumors
US8795235B2 (en) * 2006-10-06 2014-08-05 Surgiquest, Inc. Devices for and methods of performing minimally-invasive surgical procedures through a single incision
US10045860B2 (en) 2008-12-19 2018-08-14 Amicus Design Group, Llc Interbody vertebral prosthetic device with self-deploying screws
US9566165B2 (en) 2012-03-19 2017-02-14 Amicus Design Group, Llc Interbody vertebral prosthetic and orthopedic fusion device with self-deploying anchors
JP5913727B2 (ja) 2012-03-19 2016-04-27 アミカス デザイン グループ、エルエルシー 自己展開アンカーを用いた椎体間脊椎補綴整形固定デバイス
EP3033108B1 (de) 2013-08-16 2021-03-24 University Of Rochester Designte peptide zur modulation dichter verbindungsbarrieren
US20220249364A1 (en) 2019-06-05 2022-08-11 University Of Rochester Designed Inhibitors of Tight Junction Formation

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986005816A1 (en) * 1985-04-04 1986-10-09 Georgetown University Type-specific papillomavirus dna sequences and peptides
US7476389B1 (en) 1991-07-19 2009-01-13 The University Of Queensland Papillomavirus vaccines
DE122007000095I1 (de) 1992-06-25 2008-03-27 Papillomavirus vakzine
US5437951A (en) 1992-09-03 1995-08-01 The United States Of America As Represented By The Department Of Health And Human Services Self-assembling recombinant papillomavirus capsid proteins
US5618536A (en) 1992-09-03 1997-04-08 The United States Of America As Represented By The Department Of Health And Human Services Chimeric papillomavirus-like particles
DE122007000014I1 (de) 1993-03-09 2007-05-24 Univ Rochester Herstellung von menschlichem Papillomavirus Hüllprotein und virus-ähnlichen Teilchen
US6153201A (en) * 1993-03-09 2000-11-28 University Of Rochester Oral immunization with papillomavirus virus-like particles
CA2257822A1 (en) 1996-07-17 1998-01-22 The Government Of The United States Of America, Represented By The Secre Tary, Department Of Health And Human Services Infectious papillomavirus pseudoviral particles
US5980898A (en) 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization
US6165471A (en) 1997-07-03 2000-12-26 University Of Colorado, University Technology Corporation Homogeneous human papillomavirus capsomere containing compositions, methods for manufacture, and use thereof as diagnostic, prophylactic or therapeutic agents
US6228368B1 (en) 1997-10-06 2001-05-08 Loyola University Of Chicago Papilloma virus capsomere formulations and method of use
ES2289200T3 (es) 1998-02-25 2008-02-01 The Government Of The United States, As Represented By The Secretary Of The Army Uso de mejoradores para penetracion de la piel y agentes de alteracion de barrera para mejorar la respuesta inmune transcutanea.
US6835184B1 (en) * 1999-09-24 2004-12-28 Becton, Dickinson And Company Method and device for abrading skin
JP2003528818A (ja) 1999-11-10 2003-09-30 パウダージェクト ヴァクシンズ，インコーポレイテッド 皮膚経路を介したワクチン接種による粘膜免疫の誘導
WO2001066700A1 (en) 2000-03-09 2001-09-13 Emory University Transcutaneous immunization for large particulate antigens
US6595947B1 (en) * 2000-05-22 2003-07-22 Becton, Dickinson And Company Topical delivery of vaccines
US20020193729A1 (en) 2001-04-20 2002-12-19 Cormier Michel J.N. Microprojection array immunization patch and method

Also Published As

Publication number Publication date
WO2003103570A9 (en) 2004-05-06
US20050013832A1 (en) 2005-01-20
WO2003103570A2 (en) 2003-12-18
EP1425423A4 (de) 2005-07-27
CA2457804C (en) 2012-10-16
AU2002367977A1 (en) 2003-12-22
EP1425423A2 (de) 2004-06-09
US7247433B2 (en) 2007-07-24
CA2457804A1 (en) 2003-12-18
EP1425423B1 (de) 2010-06-23
AU2002367977B2 (en) 2008-06-19
WO2003103570A3 (en) 2004-02-12
ATE471990T1 (de) 2010-07-15

Similar Documents

Publication Publication Date Title
DK1216053T3 (da) Influenzavaccine
ATE465750T1 (de) Verwendung eines replikationdefizienten pockenvirusvektors zur erhöhung der cd4+ t-zell- immunantwort gegen antigen
EA200401064A1 (ru) Вирусоподобные частицы из вируса папилломы человека
EP1270016A4 (de) Aidsvirus-impfstoff unter verwendung eines sendaivirus-vektors
CY1111552T1 (el) Χρηση hpv16 και hpv18 ως εμβολιο εναντι ενος ή περισσοτερων ογκογονικου hpv τυπου 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68
DE60236806D1 (de) Transkutane immunisierung gegen papillomavirus mit virusähnlichen papillomaviruspartikeln
MY163972A (en) Attenuated recombinant newcastle disease virus and vaccine containing the same
ATE352557T1 (de) Rekombinantes nukleoprotein von newcastle- krankheitsvirus als markierungsimpfstoff
JOP20220187A1 (ar) لقاح فيروس الورم الحليمي البشري (hpv)
FI1855720T4 (fi) Muunnellun rokkoviruksen käyttö immuniteetin nopeaksi indusoimiseksi rokkovirusta tai muita infektoivia aineita vastaan
WO2006045532A3 (en) Virosome particles comprising antigens from influenza virus and hepatitis b virus
CY1113830T1 (el) Εμβολιο εναντι hpv16 και hpv18 και τουλαχιστον ενος αλλου τυπου hpv ο οποιος επιλεγεται απο hpv 31,45 ή 52
MX2007002659A (es) Composicion vacunal contra el virus de la hepatitis c.
EA201170264A1 (ru) Вакцина против hpv
TR200606983T1 (tr) Nodavirüs-VLP bağışıklaştırma bileşimi
ATE474596T1 (de) Impfstoff gegen humanes papillomavirus zur oralen verabreichung
EA200301151A1 (ru) Вакцина против натуральной оспы
UY31574A1 (es) Vacunas contra la malaria
EA200702077A1 (ru) Вакцина
ATE526035T1 (de) Tollwut-impfstoff
HUP0402548A2 (hu) Madárembrió-részecskékből álló biomassza vírusantigének előállítására
MY192396A (en) An influenza a vaccine
DE60233391D1 (de) Vakzine zum schutz von tieren gegen leishmania
UA62746C2 (en) Emulsion vaccine associated inactivated against newcastle disease, infectious bronchitis of fowls, and syndrome of decreasing egg production-76